基于Pyrazole和Pyrazoline的EGFR TK抑制剂:一项强调结构-活性关系 (SAR) 的综述研究
Shruti Mittal1, Ozair Alam1, Lakshay Singh1
1Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi-110062, India.
Medicinal chemistry (Shariqah (United Arab Emirates))
|April 18, 2025
概括
本综述探讨了pyrazole和pyrazoline衍生物作为潜在的抗癌药物,针对EGFR突变. 它强调结构-活性关系,以优化这些化合物抑制瘤生长和克服耐药性.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
背景情况:
- 皮表皮生长因子受体 (EGFR) 异常导致细胞不受控制的生长和癌的发展.
- 由于EGFR相关的基因突变,癌细胞对诸如氨酸激酶抑制剂 (TKI) 等治疗产生耐药性.
- 针对C797S突变的第四代TKI是EGFR突变癌症的当前标准.
研究的目的:
- 审查pyrazole和pyrazoline衍生物作为潜在的抗癌剂.
- 分析这些化合物的结构-活性关系 (SAR) 与EGFR氨酸激酶抑制剂.
- 为了指导新型抗扩散剂的优化.
主要方法:
- 在过去15年中开发的抗癌药物的文献综述.
- 重点关注的是pyrazole和pyrazoline衍生物.
- 对化合物活性和SAR的分析.
主要成果:
- 确定了31种潜在的抗癌化合物.
- 对于pyrazole和pyrazoline衍生物的详细活性特征和SAR.
- 作为EGFR氨酸激酶抑制剂的突出化合物.
结论:
- 皮拉和皮拉的支架显示出作为EGFR抑制剂的前景.
- SAR分析对于优化抗增殖疗效至关重要.
- 进一步的研究可能会导致改进的癌症疗法克服耐药性.
相关概念视频
Structure-Activity Relationships and Drug Design
437
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
437
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.4K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.4K
G Protein-coupled Receptors
10.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
10.7K
Allosteric Regulation
57.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.2K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Protein Kinases and Phosphatases
12.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.9K


